SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-056414
Filing Date
2013-07-25
Accepted
2013-07-25 06:05:48
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a13-13749_110q.htm 10-Q 1461139
2 EX-31.1 a13-13749_1ex31d1.htm EX-31.1 12902
3 EX-31.2 a13-13749_1ex31d2.htm EX-31.2 12868
4 EX-32.1 a13-13749_1ex32d1.htm EX-32.1 7031
5 EX-32.2 a13-13749_1ex32d2.htm EX-32.2 6994
  Complete submission text file 0001104659-13-056414.txt   16994040

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT uthr-20130630.xml EX-101.INS 1903650
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT uthr-20130630.xsd EX-101.SCH 121763
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT uthr-20130630_cal.xml EX-101.CAL 100611
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT uthr-20130630_def.xml EX-101.DEF 510173
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT uthr-20130630_lab.xml EX-101.LAB 1979094
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT uthr-20130630_pre.xml EX-101.PRE 875069
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 13984872
SIC: 2834 Pharmaceutical Preparations